{
    "2021-04-30": [
        [
            {
                "time": "2021-04-30",
                "original_text": "AbbVie Rises on Q1 Beats, Raised EPS Guidance",
                "features": {
                    "keywords": [
                        "Q1",
                        "Beats",
                        "Raised",
                        "EPS",
                        "Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-01",
                "original_text": "AbbVie Stock Nears Breakout After First-Quarter Beat And Raise",
                "features": {
                    "keywords": [
                        "Stock",
                        "Breakout",
                        "First-Quarter",
                        "Beat",
                        "Raise"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-02",
                "original_text": "AbbVie (ABBV) Q1 2021 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-03",
                "original_text": "AbbVie (ABBV) Beats on Q1 Earnings, Raises 2021 Guidance",
                "features": {
                    "keywords": [
                        "Beats",
                        "Q1",
                        "Earnings",
                        "Raises",
                        "2021",
                        "Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-04",
                "original_text": "AbbVie Stock Dips Away From Breakout Despite First-Quarter Beat And Raise",
                "features": {
                    "keywords": [
                        "Stock",
                        "Dips",
                        "Breakout",
                        "First-Quarter",
                        "Beat",
                        "Raise"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-05",
                "original_text": "How AbbVie Beat Expectations Again in Q1",
                "features": {
                    "keywords": [
                        "Beat",
                        "Expectations",
                        "Q1"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-06",
                "original_text": "AbbVie Beats Q1 Earnings On Strong Humira Sales, Raises Full-Year Profit Forecast",
                "features": {
                    "keywords": [
                        "Beats",
                        "Q1",
                        "Earnings",
                        "Strong",
                        "Humira",
                        "Sales",
                        "Raises",
                        "Full-Year",
                        "Profit",
                        "Forecast"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-07",
                "original_text": "UPDATE 2-AbbVie expects Botox sales recovery in Europe after U.S. rebound",
                "features": {
                    "keywords": [
                        "Botox",
                        "sales",
                        "recovery",
                        "Europe",
                        "U.S.",
                        "rebound"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-08",
                "original_text": "AbbVie (ABBV) Surpasses Q1 Earnings and Revenue Estimates",
                "features": {
                    "keywords": [
                        "Surpasses",
                        "Q1",
                        "Earnings",
                        "Revenue",
                        "Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "AbbVie's stock is up 2.0% as Humira sales top $4.8 billion in sales in the first quarter",
                "features": {
                    "keywords": [
                        "stock",
                        "up",
                        "Humira",
                        "sales",
                        "first",
                        "quarter"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "AbbVie Stock Pops On Earnings Beat; Raises 2021 Profit Outlook",
                "features": {
                    "keywords": [
                        "Stock",
                        "Pops",
                        "Earnings",
                        "Beat",
                        "Raises",
                        "2021",
                        "Profit",
                        "Outlook"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}